PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

MannKind Corporation

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from MannKind Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Profit Cash Ratio: Over the last 3 years, every $100 of reported profit came with $441 of operating cash. Higher than 93% of Healthcare companies in United States.
  • Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.

Where $100 of sales goes

$87Operating costs$11Interest$1.7Net profit

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

$441

Over the last 3 years, every $100 of reported profit came with $441 of operating cash.

Higher than 93% of Healthcare companies in United States.

Self-Funding Ratio

1.7×

Over the last 3 years its own operating cash covered its investment spending (capex) 1.7 times.

Higher than 72% of Healthcare companies in United States.

Cash Locked Ratio

$19

For every $100 of sales, $19 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $28 tied up three years earlier.

Less money tied up than 61% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 85% of Healthcare companies in United States.

Growth Efficiency Ratio

$37

Sales grew 250% in 3 years; of every extra $100 of sales, $37 became extra profit.

Higher than 62% of Healthcare companies in United States.

Asset Productivity Ratio

+250% / +168%

In 3 years sales changed by +250% while total assets changed by +168%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

0.5×

Debt due within a year is covered 0.5 times by its yearly operating cash.

Higher than 70% of Healthcare companies in United States.

Cash Cushion Ratio

−19%

Debt, after subtracting cash, equals 19% of its market value (net debt).

Lower than 83% of Healthcare companies in United States.

Tangible Assets Ratio

50%

Of every $100 the company owns, $50 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 80% of Healthcare companies in United States.

Tangible Net Worth Ratio

—

Data incomplete

Shareholders

Shareholder Slice Ratio

+17%

Share count rose 17% in 3 years, so each share's slice of the company became smaller.

Smaller rise in share count than 60% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (12)

MannKind Corporation made a loss over the last year. MannKind Corporation owes $1.09 for every $1 it owns. Net profit fell 79% in the year to Dec 2025.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

MannKind Corporation made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

-15.31

MannKind Corporation's book value is negative (it owes more than it owns), so P/B is not meaningful.

Market cap

$1.0 B

The total market value of all of MannKind Corporation's shares at today's price (share price × number of shares), larger than 64% of Healthcare companies in United States. PosiCap size class: Mini Cap.

Net worth (book value)

Negative

MannKind Corporation's net worth is negative ($67 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.

Owes vs Owns

1.09×

MannKind Corporation owes $1.09 for every $1 it owns, so it owes more than it owns, higher than 89% of Healthcare companies in United States.

Dividend yield

None

MannKind Corporation does not currently pay a dividend.

Revenue growth

+22%

Revenue rose 22% in the year to Dec 2025, and grew 52% a year on average over 3 years.

Profit growth

-79%

Net profit fell 79% in the year to Dec 2025.

Profit margin

1.7%

MannKind Corporation keeps $2 of every $100 of revenue as net profit.

Cash quality

3.1×

Cash from MannKind Corporation's business was 3.1× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

1.2×

MannKind Corporation's operating profit covered its interest costs 1.2 times in the year to Dec 2025.

Cash vs debt

Net debt

MannKind Corporation had $196 M more debt than cash (net debt) at Dec 2025.

Questions

How much does MannKind Corporation owe compared with what it owns?

MannKind Corporation owes $1.09 for every $1 it owns, so it owes more than it owns, higher than 89% of Healthcare companies in United States.

Does MannKind Corporation pay a dividend?

No. MannKind Corporation does not currently pay a dividend.

Is MannKind Corporation's revenue growing?

Revenue rose 22% in the year to Dec 2025, and grew 52% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.